Prospective Study of lncRNA NORAD for Predicting Cerebrovascular Events in Asymptomatic Patients with Carotid Artery Stenosis

Background Carotid artery stenosis (CAS) may cause many cerebrovascular diseases, and a biomarker for screening and monitoring is needed. This study focused on the clinical significance of long-chain non-coding RNA (lncRNA) non-coding RNA activated by DNA damage (NORAD) in patients with CAS and aime...

Full description

Saved in:
Bibliographic Details
Main Authors: Yan Fan, Yan Ma, Rui Wang, Lili Wang
Format: Article
Language:English
Published: SAGE Publishing 2025-01-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/10760296241299792
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841556498938855424
author Yan Fan
Yan Ma
Rui Wang
Lili Wang
author_facet Yan Fan
Yan Ma
Rui Wang
Lili Wang
author_sort Yan Fan
collection DOAJ
description Background Carotid artery stenosis (CAS) may cause many cerebrovascular diseases, and a biomarker for screening and monitoring is needed. This study focused on the clinical significance of long-chain non-coding RNA (lncRNA) non-coding RNA activated by DNA damage (NORAD) in patients with CAS and aimed to search for potential biomarkers of CAS. Methods Eighty-six asymptomatic patients with CAS and 60 healthy individuals were enrolled, with corresponding clinical data and serum samples collected. The expression of NORAD was detected by reverse transcription-quantitive PCR (RT-qPCR). All patients were followed up for 2 years to collected the occurrence data of cerebrovascular events, and Kaplan-Meier and Cox regression were used for data analysis. Receiver operator characteristic curve was used to analyze the diagnostic value of NORAD in distinguishing CAS patients from healthy people, and to evaluate the prediction accuracy of NORAD. Results NORAD is overexpressed in the serum of CAS patients, and associated with patients’ hypertension, TC, LDL-C levels and stenosis degree. NORAD has high sensitivity (88.37%) and specificity (80.00%) in the identification of CAS patients (AUC = 0.917). NORAD was independently related to the occurrence of cerebrovascular events (HR = 2.435, P  = .003). a logistic regression risk model for predicting cerebrovascular events was constructed with the parameters including NORAD, TC and LDL. Conclusion NORAD can be used as a diagnostic and prognostic biomarker for CAS, and NORAD, total cholesterol (TC), and low density lipoprotein cholesterol (LDL-C) can be independently correlated to predict cerebrovascular events.
format Article
id doaj-art-654bfe66fb784832b09154f5a0cd90d6
institution Kabale University
issn 1938-2723
language English
publishDate 2025-01-01
publisher SAGE Publishing
record_format Article
series Clinical and Applied Thrombosis/Hemostasis
spelling doaj-art-654bfe66fb784832b09154f5a0cd90d62025-01-07T08:04:29ZengSAGE PublishingClinical and Applied Thrombosis/Hemostasis1938-27232025-01-013110.1177/10760296241299792Prospective Study of lncRNA NORAD for Predicting Cerebrovascular Events in Asymptomatic Patients with Carotid Artery StenosisYan Fan0Yan Ma1Rui Wang2Lili Wang3 Department of Neurology, , Liaocheng, Shandong, China Department of Hyperbaric Oxygen, , Liaocheng, Shandong, China Department of Neurology, , Liaocheng, Shandong, China Department of Neurology, , Liaocheng, Shandong, ChinaBackground Carotid artery stenosis (CAS) may cause many cerebrovascular diseases, and a biomarker for screening and monitoring is needed. This study focused on the clinical significance of long-chain non-coding RNA (lncRNA) non-coding RNA activated by DNA damage (NORAD) in patients with CAS and aimed to search for potential biomarkers of CAS. Methods Eighty-six asymptomatic patients with CAS and 60 healthy individuals were enrolled, with corresponding clinical data and serum samples collected. The expression of NORAD was detected by reverse transcription-quantitive PCR (RT-qPCR). All patients were followed up for 2 years to collected the occurrence data of cerebrovascular events, and Kaplan-Meier and Cox regression were used for data analysis. Receiver operator characteristic curve was used to analyze the diagnostic value of NORAD in distinguishing CAS patients from healthy people, and to evaluate the prediction accuracy of NORAD. Results NORAD is overexpressed in the serum of CAS patients, and associated with patients’ hypertension, TC, LDL-C levels and stenosis degree. NORAD has high sensitivity (88.37%) and specificity (80.00%) in the identification of CAS patients (AUC = 0.917). NORAD was independently related to the occurrence of cerebrovascular events (HR = 2.435, P  = .003). a logistic regression risk model for predicting cerebrovascular events was constructed with the parameters including NORAD, TC and LDL. Conclusion NORAD can be used as a diagnostic and prognostic biomarker for CAS, and NORAD, total cholesterol (TC), and low density lipoprotein cholesterol (LDL-C) can be independently correlated to predict cerebrovascular events.https://doi.org/10.1177/10760296241299792
spellingShingle Yan Fan
Yan Ma
Rui Wang
Lili Wang
Prospective Study of lncRNA NORAD for Predicting Cerebrovascular Events in Asymptomatic Patients with Carotid Artery Stenosis
Clinical and Applied Thrombosis/Hemostasis
title Prospective Study of lncRNA NORAD for Predicting Cerebrovascular Events in Asymptomatic Patients with Carotid Artery Stenosis
title_full Prospective Study of lncRNA NORAD for Predicting Cerebrovascular Events in Asymptomatic Patients with Carotid Artery Stenosis
title_fullStr Prospective Study of lncRNA NORAD for Predicting Cerebrovascular Events in Asymptomatic Patients with Carotid Artery Stenosis
title_full_unstemmed Prospective Study of lncRNA NORAD for Predicting Cerebrovascular Events in Asymptomatic Patients with Carotid Artery Stenosis
title_short Prospective Study of lncRNA NORAD for Predicting Cerebrovascular Events in Asymptomatic Patients with Carotid Artery Stenosis
title_sort prospective study of lncrna norad for predicting cerebrovascular events in asymptomatic patients with carotid artery stenosis
url https://doi.org/10.1177/10760296241299792
work_keys_str_mv AT yanfan prospectivestudyoflncrnanoradforpredictingcerebrovasculareventsinasymptomaticpatientswithcarotidarterystenosis
AT yanma prospectivestudyoflncrnanoradforpredictingcerebrovasculareventsinasymptomaticpatientswithcarotidarterystenosis
AT ruiwang prospectivestudyoflncrnanoradforpredictingcerebrovasculareventsinasymptomaticpatientswithcarotidarterystenosis
AT liliwang prospectivestudyoflncrnanoradforpredictingcerebrovasculareventsinasymptomaticpatientswithcarotidarterystenosis